Sanara MedTech CEO reports tax-share withholding

Sanara MedTech Inc. director and Chief Executive Officer Yon Seth D reported a tax-related share withholding tied to restricted stock vesting.

Rhea-AI Filing Summary

Sanara MedTech Inc. director and Chief Executive Officer Yon Seth D reported a tax-related share withholding tied to restricted stock vesting. The company withheld 873 shares of common stock to cover tax obligations when 3,049 previously granted restricted shares vested, and no shares were issued or sold in the market. After this withholding, Yon Seth D directly owns 88,978 shares of Sanara MedTech common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 873 shares

Exercise Price or Tax Liability 1 txn

Insider Yon Seth D

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	873	$19.90	$17K

Holdings After Transaction: Common Stock — 88,978 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 3,049 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sanara MedTech (SMTI) report for Yon Seth D?

Sanara MedTech reported a tax-withholding disposition for CEO Yon Seth D. 873 shares of common stock were withheld to satisfy tax obligations related to the vesting of 3,049 restricted shares previously granted to him.

Was the Sanara MedTech (SMTI) insider Form 4 a market sale of shares?

No, the filing states no shares were issued or sold in the market. The 873 shares of common stock were withheld by the company solely to cover tax withholding obligations on vested restricted stock.

How many Sanara MedTech (SMTI) shares were involved in the tax withholding?

The company withheld 873 shares of Sanara MedTech common stock. These shares were used to satisfy tax withholding requirements triggered by the annual vesting of 3,049 restricted stock shares previously granted to the CEO.

How many Sanara MedTech (SMTI) shares does Yon Seth D own after this Form 4 transaction?

Following the tax-withholding disposition, Yon Seth D directly owns 88,978 shares of Sanara MedTech common stock. This figure reflects his direct holdings after the company withheld 873 shares to cover tax obligations on vested restricted stock.

What does transaction code F mean in the Sanara MedTech (SMTI) Form 4?

Transaction code F indicates payment of an exercise price or tax liability by delivering securities. In this case, 873 shares were withheld by Sanara MedTech to satisfy tax withholding on the vesting of 3,049 restricted stock shares.

Did the Sanara MedTech (SMTI) CEO buy or sell any shares in this Form 4?

The CEO did not report open-market buys or sells. Instead, 873 shares were disposed of as a tax-withholding transaction, with the issuer retaining shares to cover taxes on the vesting of 3,049 restricted shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:27 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yon Seth D

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TX 76102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		F		873(1)	D	$19.9(1)	88,978	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 3,049 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Seth D. Yon	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.